BIT 6.67% 3.2¢ biotron limited

$10 Billion Deal, page-11927

  1. 665 Posts.
    lightbulb Created with Sketch. 129
    Not against BP, we will most likely complement what they have in their pipelines. We compete with other non commercial preclinical research labs and smaller biotechs. We were in the same boat now as we were with with HepC development, BP will have their own tech but probably require further IP from smaller operations such as Gilead did with sofosbuvir. It's competitive.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.